393 research outputs found
Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer
Pancreatic cancer is a highly lethal disease with a genetic susceptibility and familial aggregation found in 3%-16% of patients. Early diagnosis remains the only hope for curative treatment and improvement of prognosis. This can be reached by the implementation of an intensive screening program, actually recommended for individuals at high-risk for pancreatic cancer development. The aim of this strategy is to identify pre-malignant precursors or asymptomatic pancreatic cancer lesions, curable by surgery. Endoscopic ultrasound (EUS) with or without fine needle aspiration (FNA) seems to be the most promising technique for early detection of pancreatic cancer. It has been described as a highly sensitive and accurate tool, especially for small and cystic lesions. Pancreatic intraepithelial neoplasia, a precursor lesion which is highly represented in high-risk individuals, seems to have characteristics chronic pancreatitis-like changes well detected by EUS. Many screening protocols have demonstrated high diagnostic yields for pancreatic pre-malignant lesions, allowing prophylactic pancreatectomies. However, it shows a high interobserver variety even among experienced endosonographers and a low sensitivity in case of chronic pancreatitis. Some new techniques such as contrast-enhanced harmonic EUS, computer-aided diagnostic techniques, confocal laser endomicroscopy miniprobe and the detection of DNA abnormalities or protein markers by FNA, promise improvement of the diagnostic yield of EUS. As the resolution of imaging improves and as our knowledge of precursor lesions grows, we believe that EUS could become the most suitable method to detect curable pancreatic neoplasms in correctly identified asymptomatic at-risk patients
Status and Perspectives of High Luminosity Flavour Factories
The quest for high precision measurements in rare flavor decays requires dedicated colliders with very high peak luminosity and high operation reliability, in order to collect the huge amount of data needed. In the past such Factories were in operation at SLAC (USA) and KEK (Japan) for the study of the B mesons decays, and are still collecting data at IHEP (China) at the Tau/charm energy and at LNF (Italy) and BINP (Russia) at the Φ resonance. Future projects, such as SuperKEKB in Japan, already in the assembly phase, and Tau/charm colliders proposals at BINP and LNF, will deal with a different frontier of experimental subnuclear physics, with a research program complementary to CERN's LHC, by increasing the rate of particle beam collisions at a level that has never been reached before, producing extremely rare physical events which are influenced by the potential existence of new massive particles and thus provide unique information on them. A status of the present facilities and future projects in the "low energy, high luminosity" region will be presented
Seizure progression is slowed by enhancing neurosteroid availability in the brain of epileptic rats
Trilostane is a 3β-hydroxysteroid
dehydrogenase/Δ5-4
isomerase inhibitor able to
produce a manyfold increase in brain levels of various neurosteroids, including
allopregnanolone. We previously found that treatment with trilostane can slow
down epileptogenesis in the kainic acid (KA) model of temporal lobe epilepsy. It
is unknown whether trilostane may have a similar effect on the progression of
epilepsy severity, as observed in KA-treated
rats. Consequently, we investigated
the effects of trilostane (50 mg/kg/day, 1 week) in epileptic rats, given 64 days
after KA administration. Seizures were monitored by video-electrocorticographic
recordings before and during the treatment with trilostane or vehicle (sesame
oil), and neurosteroid levels were measured in serum and cerebral tissue using
liquid chromatography–electrospray tandem mass spectrometry after treatment.
Pregnenolone sulfate, pregnenolone, progesterone, 5α-dihydroprogesterone,
and allopregnanolone peripheral levels were massively increased by trilostane.
With the only exception of hippocampal pregnenolone sulfate, the other neurosteroids
augmented in both the neocortex and hippocampus. Only pregnanolone
levels were not upregulated by trilostane. As expected, a significant increase in
the seizure occurrence was observed in rats receiving the vehicle, but not in the
trilostane group. This suggests that the increased availability of neurosteroids
produced a disease-modifying
effect in the brain of epileptic rats
Main-duct intraductal papillary mucinous neoplasm of the pancreas: a case report
Three distinct entities among non-inflammatory cystic lesions of the pancreas have been defined: intraductal papillary mucinous neoplasm (IPMN), serous cystic neoplasm (SCN) and mucinous cystic neoplasm (MCN). IPMN is characterized by intraductal papillary growth and thick mucus secretion: its incidence has dramatically increased since its initial description. These lesions probably can progress towards invasive carcinoma. IPMNs are symptomatic in most cases: the typical presentation is a recurrent acute pancreatitis, without evident cause, of low or moderate severity. The diagnosis is usually based upon the imaging (CT/cholangio-MRI) demonstrating a pancreatic cystic mass, involving a dilated main duct, eventually associated to some filling defects, or a normal Wirsung duct communicating with the cyst lesion. Surgical treatment is generally indicated for main duct IPMN and branch duct IPMN with suspected malignancy (tumour size ≥ 30 mm, mural nodules, dilated main pancreatic duct, or positive cytology) or prominent symptoms. Herein we present a case of IPMN of the main duct which occurred with abdominal and back pain associated with weight loss. After the diagnosis, she successfully underwent surgery and is now in a follow-up program
Sarcoidosis presenting with splenomegaly and abdominal pain: a case report
Sarcoidosis is a multisystemic disease of unknown aetiology characterized by proliferation of noncaseating granulomas at disease sites. It commonly affects young and middle-age adults and frequently presents with pulmonary infiltration, bilateral hilar lymphadenopathy, ocular and skin lesions. The liver, spleen, lymph nodes, salivary glands, heart, nervous system, muscles, bones, and other organs may also be involved. A diagnosis of the disorder usually requires the demonstration of typical lesions in more than one organ system and exclusion of other disorder known to cause granulomatous inflammation. We present the case of a young woman with abdominal pain and weight loss. The finding of splenomegaly by abdominal ultrasound and the presence of hypercalciuria, hypercalcemia and mild renal impairment led us to include sarcoidosis in the differential diagnosis. The final diagnosis was established by demonstration of involvement of lymph nodes and lung parenchyma on CT scan, and typical histology in bioptic specimens collected from bronchial mucosa
- …